FDA Approved: OMVOH — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

FDA approved a supplemental application for OMVOH (mirikizumab-MRKZ) submitted by Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• OMVOH (MIRIKIZUMAB-MRKZ)

Snippet

SUPPL AP for OMVOH (MIRIKIZUMAB-MRKZ)